RAIMONDI, SARA
RAIMONDI, SARA
Universita' degli Studi di MILANO
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma]
2023 L. Lavinia Travaini, F. Botta, E. Derenzini, G. Lo Presti, M. Esmeralda Ferrari, L. Simona Air(`(o)) Farulla, T. Radice, S. Mazzara, C. Tarella, S. Pileri, S. Raimondi, F. Ceci
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
2023 S. Mazzara, L. Travaini, F. Botta, C. Granata, G. Motta, F. Melle, S. Fiori, V. Tabanelli, A. Vanazzi, S. Ramadan, T. Radice, S. Raimondi, G. Lo Presti, M.E. Ferrari, B.A. Jereczek-Fossa, C. Tarella, F. Ceci, S. Pileri, E. Derenzini
European Cohorts of patients and schools to Advance Response to Epidemics (EuCARE): a cluster randomised interventional and observational study protocol to investigate the relationship between schools and SARS-CoV-2 infection
2023 S. Raimondi, S. Gandini, G.H. Rubio Quintanares, A. Abecasis, P.L. Lopalco, O. D'Ecclesiis, S. Chiocca, E. Tomezzoli, I. Cutica, D. Mazzoni, N. Amparo, M. Pingarilho, D. Carmagnola, C. Dellavia, G. Zuccotti, C. Ronchini, F. Bellerba, F. Dewald, R. Kaiser, F. Incardona
Radiomic Features Applied to Contrast Enhancement Spectral Mammography: Possibility to Predict Breast Cancer Molecular Subtypes in a Non-Invasive Manner
2022 L. Nicosia, A.C. Bozzini, D. Ballerini, S. Palma, F. Pesapane, S. Raimondi, A. Gaeta, F. Bellerba, D. Origgi, P. De Marco, G. Castiglione Minischetti, C. Sangalli, L. Meneghetti, G. Curigliano, E. Cassano
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients
2021 S. Dicuonzo, M.C. Leonardi, S. Raimondi, G. Corrao, V. Bagnardi, M.A. Gerardi, A. Morra, M.A. Zerella, M. Zaffaroni, F. Pansini, F. Cattani, R. Luraschi, C. Fodor, P. Veronesi, R. Orecchia, D.P. Rojas, B.A. Jereczek-Fossa
The Challenge of Choosing the Best Classification Method in Radiomic Analyses: Recommendations and Applications to Lung Cancer CT Images
2021 F. Corso, G. Tini, G. Lo Presti, N. Garau, S.P. De Angelis, F. Bellerba, L. Rinaldi, F. Botta, S. Rizzo, D. Origgi, C. Paganelli, M. Cremonesi, C. Rampinelli, M. Bellomi, L. Mazzarella, P.G. Pelicci, S. Gandini, S. Raimondi
Gender-Dependent Specificities in Cutaneous Melanoma Predisposition, Risk Factors, Somatic Mutations, Prognostic and Predictive Factors : A Systematic Review
2021 O. D’Ecclesiis, S. Caini, C. Martinoli, S. Raimondi, C. Gaiaschi, G. Tosti, P. Queirolo, C. Veneri, C. Saieva, S. Gandini, S. Chiocca
Recent radiomics advancements in breast cancer: Lessons and pitfalls for the next future
2021 F. Pesapane, A. Rotili, G.M. Agazzi, F. Botta, S. Raimondi, S. Penco, V. Dominelli, M. Cremonesi, B.A. Jereczek-Fossa, G. Carrafiello, E. Cassano
Association of a CT-Based Clinical and Radiomics Score of Non-Small Cell Lung Cancer (NSCLC) with Lymph Node Status and Overall Survival
2020 F. Botta, S. Raimondi, L. Rinaldi, F. Bellerba, F. Corso, V. Bagnardi, D. Origgi, R. Minelli, M.G. Pitoni, F. Petrella, L. Spaggiari, A.G. Morganti, F. Del Grande, M. Bellomi, S.M.R. Rizzo
Association of quantitative mri-based radiomic features with prognostic factors and recurrence rate in oropharyngeal squamous cell carcinoma
2020 C. Giannitto, G. Marvaso, F. Botta, S. Raimondi, D. Alterio, D. Ciardo, S. Volpe, F. de Piano, E. Ancona, M. Tagliabue, D. Origgi, S. Chiocca, F.A. Maffini, M. Ansarin, V. Bagnardi, F. Cattani, F. Nole, L. Preda, R. Orecchia, E. Cassano, M. Cremonesi, A. Starzynska, M. Bellomi, B.A. Jereczek-Fossa
Inter-observer agreement on the morphology of screening-detected lung cancer: beyond pulmonary nodules and masses
2019 C. Rampinelli, M. Minotti, E. Ancona, L. Preda, R. Bertolotti, P. Summers, S. Raimondi, V. Bagnardi, M. Bellomi
Radiomics of high-grade serous ovarian cancer : association between quantitative CT features, residual tumour and disease progression within 12 months
2018 S. Rizzo, F. Botta, S. Raimondi, D. Origgi, V. Buscarino, A. Colarieti, F. Tomao, G. Aletti, V. Zanagnolo, M. Del Grande, N. Colombo, M. Bellomi
Radiomics : the facts and the challenges of image analysis
2018 S. Rizzo, F. Botta, S. Raimondi, D. Origgi, C. Fanciullo, A.G. Morganti, M. Bellomi
Evaluation of inter-observer variability according to RECIST 1.1 and its influence on response classification in CT measurement of liver metastases
2017 M. Bellomi, F. De Piano, E. Ancona, A. Ferla Lodigiani, G. Curigliano, S. Raimondi, L. Preda
Diagnostic accuracy of surface coil MRI in assessing cartilaginous invasion in laryngeal tumours: Do we need contrast-agent administration?
2017 L. Preda, G. Conte, L. Bonello, C. Giannitto, E. Tagliabue, S. Raimondi, M. Ansarin, L. de Benedetto, A. Cattaneo, F. Maffini, M. Bellomi
Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study
2017 G. Conte, L. Preda, E. Cocorocchio, S. Raimondi, C. Giannitto, M. Minotti, F. DE PIANO, G. Petralia, P.F. Ferrucci, M. Bellomi
Squamous cell carcinoma of the oral cavity and oropharynx : what does the apparent diffusion coefficient tell us about its histology?
2016 L. Bonello, L. Preda, G. Conte, C. Giannitto, S. Raimondi, M. Ansarin, F. Maffini, P. Summers, M. Bellomi
Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma
2016 L. Preda, G. Conte, L. Bonello, C. Giannitto, L.L. Travaini, S. Raimondi, P.E. Summers, A. Mohssen, D. Alterio, M. Cossu Rocca, C. Grana, F. Ruju, M. Bellomi
CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
2016 S. Rizzo, F. Petrella, V. Buscarino, F. de Maria, S. Raimondi, M. Barberis, C. Fumagalli, G. Spitaleri, C. Rampinelli, F. de Marinis, L. Spaggiari, M. Bellomi
Evaluation of diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as early response biomarkers in cervical cancer patients
2016 S. Rizzo, V. Buscarino, D. Origgi, P. Summers, S. Raimondi, R. Lazzari, F. Landoni, M. Bellomi